Lars Thim
18Patents
8h-index
51Co-inventors
75Inventor score
Filing activity: Mar 9, 1981 → May 8, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7411039B2 | GLP-2 compounds, formulations, and uses thereof | Human Necessities | 67 | Expired |
| US5912229A | Use of a pharmaceutical composition comprising an appetite-suppressing peptide | Human Necessities | 59 | Expired |
| US5705482A | Pharmaceutical formulation | Human Necessities | 34 | Expired |
| US4916212A | DNA-sequence encoding biosynthetic insulin precursors and process for preparing the insulin precursors and human insulin | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4826763A | Process for preparing glucagon or fragments or derivatives thereof in yeast | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4816441A | Peptides and compositions | Human Necessities | 10 | Expired |
| US5051371A | Modified .beta..sub.2 -microglobulin | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5175113A | Modified .beta..sub.2 -microglobulin | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5783416A | Human spasmolytic polypeptide in glycosylated form | Human Necessities | 7 | Expired |
| US6022858A | Pharmaceutical formulation of human-growth hormone pretreated with zinc salt | Human Necessities | 7 | Expired |
| US4370317A | Pancreatic spasmolytic polypeptide | Human Necessities | 7 | Expired |
| US5552385A | Pharmaceutical formulation | Chemistry; Metallurgy | 6 | Expired |
| US4405608A | Novel peptide | Human Necessities | 1 | Expired |
| US6458927B1 | Polypeptide with appetite regulating activity | Human Necessities | 0 | Expired |
| US8399620B2 | Purification of factor VIII using a mixed-mode or multimodal resin | Chemistry; Metallurgy | 0 | Active |
| US9125890B2 | Compounds suitable for treatment of haemophilia | Human Necessities | 0 | Active |
| US9150848B2 | Conjugated factor VIII molecules | Human Necessities | 0 | Active |
| US8536126B2 | Conjugated factor VIII molecules | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.